Suivant

Lecture automatique

Dr. William on Brentuximab Vedotin/Lenalidomide in Cutaneous/Peripheral T-Cell Lymphomas

1 Vues • 08/09/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Basem William, MD, MRCP, FACP associate professor of internal medicine, The Ohio State University, discusses the preliminary results of the phase II trial of brentuximab vedotin and lenalidomide in relapsed/refractory cutaneous and peripheral T-cell lymphomas.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive/

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique